Page last updated: 2024-11-06

floxuridine and Corridor Disease

floxuridine has been researched along with Corridor Disease in 2 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Irvin, AD1
Stagg, DA1
Moulton, JE1
Krauss, HH1
Malmquist, WA1

Other Studies

2 other studies available for floxuridine and Corridor Disease

ArticleYear
Theileria parva: purine and pyrimidine metabolism and the action of folate antagonists in parasitized bovine lymphoid cells.
    Experimental parasitology, 1977, Volume: 41, Issue:1

    Topics: Adenine; Aminopterin; Animals; Azaguanine; Cattle; Cells, Cultured; Culture Media; Eukaryota; Floxur

1977
Growth characteristics of Theileria parva-infected bovine lymphoblast cultures.
    American journal of veterinary research, 1971, Volume: 32, Issue:9

    Topics: Animals; Cattle; Cell Division; Cells, Cultured; Culture Media; Cytoplasm; Dactinomycin; DNA; Eukary

1971